Interleukin-10 As a Neuroprotective Factor in Glaucoma

Principal Investigator
Tatjana Jakobs, MD
The Schepens Eye Research Institute, Mass. Eye and Ear
Boston, MA, USA
About the Research Project
Program
Award Type
Standard
Award Amount
$182,000
Active Dates
July 01, 2025 - June 30, 2027
Grant ID
G2025008S
Goals
The goal is to investigate the role of immune cells (microglia) in glaucoma and test factors secreted by microglia for neuroprotective activity in glaucoma.
Summary
Visual impairment in glaucoma is caused by the degeneration and eventual death of retinal ganglion cells through mechanisms that are not fully understood. Retinal microglia can play neuroprotective and neurotoxic roles in glaucoma. We identified IL10 as a candidate for a microglia-derived factor that may selectively boost the neuroprotective effects.
Unique and Innovative
We identified IL10 as a microglia-derived factor with potential neuroprotective effects on retinal ganglion cells. We will test this with assays of visual function and microscopic analysis of ganglion cell morphology.
Foreseeable Benefits
Ultimately, we hope to develop a combination of several factors that can be administered to prevent ganglion cell loss in glaucoma. We also hope to gain insight into the function of immune cells in neurodegenerative diseases such as glaucoma or Alzheimer’s disease.
Related Grants
National Glaucoma Research
Mitochondria in Retinal Ganglion Cells
Active Dates
July 01, 2025 - June 30, 2027
Principal Investigator
Rob Nickells, PhD
Current Organization
University of Wisconsin-Madison
Mitochondria in Retinal Ganglion Cells
Active Dates
July 01, 2025 - June 30, 2027

Principal Investigator
Rob Nickells, PhD
Current Organization
University of Wisconsin-Madison
National Glaucoma Research
Role of a Key Gene, Angptl7, in Steroid-Induced Glaucoma
Active Dates
July 01, 2025 - June 30, 2027
Principal Investigator
W. Daniel Stamer, PhD
Current Organization
Duke University
Role of a Key Gene, Angptl7, in Steroid-Induced Glaucoma
Active Dates
July 01, 2025 - June 30, 2027

Principal Investigator
W. Daniel Stamer, PhD
Current Organization
Duke University
National Glaucoma Research
Assessment of Vascular Resistance in Glaucoma
Active Dates
July 01, 2025 - June 30, 2027
Principal Investigator
Brad Fortune, OD, PhD
Current Organization
Legacy Devers Eye Institute
Assessment of Vascular Resistance in Glaucoma
Active Dates
July 01, 2025 - June 30, 2027

Principal Investigator
Brad Fortune, OD, PhD
Current Organization
Legacy Devers Eye Institute